171 related articles for article (PubMed ID: 38134062)
81. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
[TBL] [Abstract][Full Text] [Related]
82. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population.
Papatheodoridis GV; Sypsa V; Dalekos G; Yurdaydin C; van Boemmel F; Buti M; Goulis J; Calleja JL; Chi H; Manolakopoulos S; Loglio A; Siakavellas S; Gatselis N; Keskın O; Lehretz M; Savvidou S; de la Revilla J; Hansen BE; Kourikou A; Vlachogiannakos I; Galanis K; Idilman R; Colombo M; Esteban R; Janssen HLA; Berg T; Lampertico P
J Hepatol; 2018 Jun; 68(6):1129-1136. PubMed ID: 29427727
[TBL] [Abstract][Full Text] [Related]
83. Cardiovascular and Other Competing Causes of Death in Male Breast Cancer Patients: A Population-Based Epidemiologic Study.
Zhang H; Lin W; Chen D; Wang K; Tu W; Lin H; Li K; Ye S; Guan T; Chen Y
Clin Interv Aging; 2021; 16():1393-1401. PubMed ID: 34321871
[TBL] [Abstract][Full Text] [Related]
84. Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
Rodríguez M; González-Diéguez ML; Varela M; Cadahía V; Andrés-Vizán SM; Mesa A; Castaño A; Alvarez-Navascués C
Am J Gastroenterol; 2021 Dec; 116(12):2390-2398. PubMed ID: 34569986
[TBL] [Abstract][Full Text] [Related]
85. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
[TBL] [Abstract][Full Text] [Related]
86. Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country.
Goutté N; Sogni P; Bendersky N; Barbare JC; Falissard B; Farges O
J Hepatol; 2017 Mar; 66(3):537-544. PubMed ID: 27773614
[TBL] [Abstract][Full Text] [Related]
87. Elevated fasting serum glucose levels increase the risk of hepatocellular carcinoma: A prospective cohort study.
Liu T; Wang W; Cui H; Sun M; Wang Y; Liu X; Cao L; Liu H; Liu S
Medicine (Baltimore); 2019 Jul; 98(30):e16369. PubMed ID: 31348238
[TBL] [Abstract][Full Text] [Related]
88. Incidence of cardiovascular mortality among head and neck cancer patients.
Cao LL; Wang Y; Wang SH; Yu BB; Fan J
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38724856
[TBL] [Abstract][Full Text] [Related]
89. The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy.
Coffin CS; Rezaeeaval M; Pang JX; Alcantara L; Klein P; Burak KW; Myers RP
Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1262-9. PubMed ID: 25312649
[TBL] [Abstract][Full Text] [Related]
90. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
[TBL] [Abstract][Full Text] [Related]
91. Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study.
Ziada DH; El Sadany S; Soliman H; Abd-Elsalam S; Salama M; Hawash N; Selim A; Hamisa M; Elsabagh HM
J Egypt Natl Canc Inst; 2016 Dec; 28(4):257-262. PubMed ID: 27378258
[TBL] [Abstract][Full Text] [Related]
92. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
[TBL] [Abstract][Full Text] [Related]
93. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
Zhang XX; Wang LF; Jin L; Li YY; Hao SL; Shi YC; Zeng QL; Li ZW; Zhang Z; Lau GK; Wang FS
World J Gastroenterol; 2015 Mar; 21(12):3554-63. PubMed ID: 25834320
[TBL] [Abstract][Full Text] [Related]
94. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States.
Sahasrabuddhe VV; Shiels MS; McGlynn KA; Engels EA
Cancer; 2012 Dec; 118(24):6226-33. PubMed ID: 22736272
[TBL] [Abstract][Full Text] [Related]
95. Causes of death in people with chronic HBV infection: A population-based cohort study.
Montuclard C; Hamza S; Rollot F; Evrard P; Faivre J; Hillon P; Di Martino V; Minello A
J Hepatol; 2015 Jun; 62(6):1265-71. PubMed ID: 25625233
[TBL] [Abstract][Full Text] [Related]
96. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
[TBL] [Abstract][Full Text] [Related]
97. Raised cardiovascular disease mortality after central nervous system tumor diagnosis: analysis of 171,926 patients from UK and USA.
Jin K; Brennan PM; Poon MTC; Sudlow CLM; Figueroa JD
Neurooncol Adv; 2021; 3(1):vdab136. PubMed ID: 34647025
[TBL] [Abstract][Full Text] [Related]
98. Cardiovascular-specific mortality and risk factors in colorectal Cancer patients: A cohort study based on registry data of over 500,000 individuals in the US.
Zhang T; Zhu H; Hu H; Hu H; Zhan W; Jiang L; Tang M; Escobar D; Huang W; Feng Y; Zhou J; Zou M
Prev Med; 2024 Feb; 179():107796. PubMed ID: 38070711
[TBL] [Abstract][Full Text] [Related]
99. Long-term risks of cardiovascular death among older patients with major hematological malignancies: a population-based cohort study from SEER database.
Zhang H; He M; Zhang P; Gao Y; Ouyang L; He X; Han N; Zhang J; Guan M; Feng Y; Li Y
Cancer Epidemiol Biomarkers Prev; 2024 May; ():. PubMed ID: 38713156
[TBL] [Abstract][Full Text] [Related]
100. Analysis of competing risks of cardiovascular death in patients with hepatocellular carcinoma: A population-based study.
Cao L; Wang X; Yan Y; Ning Z; Ma L; Li Y
Medicine (Baltimore); 2023 Dec; 102(51):e36705. PubMed ID: 38134062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
